Senate and House Journals
Author: Kansas. Legislature. Senate
Publisher:
Published: 1919
Total Pages: 784
ISBN-13:
DOWNLOAD EBOOKRead and Download eBook Full
Author: Kansas. Legislature. Senate
Publisher:
Published: 1919
Total Pages: 784
ISBN-13:
DOWNLOAD EBOOKAuthor: Ohio. General Assembly. Senate
Publisher:
Published: 1925
Total Pages: 114
ISBN-13:
DOWNLOAD EBOOKAuthor: John V. Sullivan
Publisher:
Published: 2007
Total Pages: 72
ISBN-13:
DOWNLOAD EBOOKAuthor: Citizens Against Government Waste
Publisher: Macmillan
Published: 2005-04-06
Total Pages: 212
ISBN-13: 9780312343576
DOWNLOAD EBOOKA compendium of the most ridiculous examples of Congress's pork-barrel spending.
Author: United States. Congress
Publisher:
Published: 1968
Total Pages: 1324
ISBN-13:
DOWNLOAD EBOOKAuthor: Thomas Wischmeyer
Publisher: Springer Nature
Published: 2019-11-29
Total Pages: 391
ISBN-13: 3030323617
DOWNLOAD EBOOKThis book assesses the normative and practical challenges for artificial intelligence (AI) regulation, offers comprehensive information on the laws that currently shape or restrict the design or use of AI, and develops policy recommendations for those areas in which regulation is most urgently needed. By gathering contributions from scholars who are experts in their respective fields of legal research, it demonstrates that AI regulation is not a specialized sub-discipline, but affects the entire legal system and thus concerns all lawyers. Machine learning-based technology, which lies at the heart of what is commonly referred to as AI, is increasingly being employed to make policy and business decisions with broad social impacts, and therefore runs the risk of causing wide-scale damage. At the same time, AI technology is becoming more and more complex and difficult to understand, making it harder to determine whether or not it is being used in accordance with the law. In light of this situation, even tech enthusiasts are calling for stricter regulation of AI. Legislators, too, are stepping in and have begun to pass AI laws, including the prohibition of automated decision-making systems in Article 22 of the General Data Protection Regulation, the New York City AI transparency bill, and the 2017 amendments to the German Cartel Act and German Administrative Procedure Act. While the belief that something needs to be done is widely shared, there is far less clarity about what exactly can or should be done, or what effective regulation might look like. The book is divided into two major parts, the first of which focuses on features common to most AI systems, and explores how they relate to the legal framework for data-driven technologies, which already exists in the form of (national and supra-national) constitutional law, EU data protection and competition law, and anti-discrimination law. In the second part, the book examines in detail a number of relevant sectors in which AI is increasingly shaping decision-making processes, ranging from the notorious social media and the legal, financial and healthcare industries, to fields like law enforcement and tax law, in which we can observe how regulation by AI is becoming a reality.
Author: Ohio. General Assembly. House of Representatives
Publisher:
Published: 1977
Total Pages: 348
ISBN-13:
DOWNLOAD EBOOKAuthor: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
Published: 2017-09-28
Total Pages: 483
ISBN-13: 0309459575
DOWNLOAD EBOOKDrug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.